elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Vasculitis
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Vasculitis
RIS
0.002
(Research Intensity Score)
Papers
204
Top papers
Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
2020 · 1817 citations
SARS-CoV-2 crosses the blood–brain barrier accompanied with basement membrane disruption without tight junctions alteration
2021 · 314 citations
New Halogen-Containing Drugs Approved by FDA in 2021: An Overview on Their Syntheses and Pharmaceutical Use
2022 · 161 citations
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends
2024 · 30 citations
Comparison of [18F]FAPI-42 and [18F]FDG PET/CT in the evaluation of systemic vasculitis
2024 · 26 citations
Newest papers
Giant Cell Arteritis as a Form of Pembrolizumab-Associated Vascular Toxicity
2026 · 1 citations
Quantitative iodine-mapping of photon-counting CT detects large-vessel vasculitis: A case report
2026
Targeting ferroptosis in ocular diseases: mechanisms, clinical implications, and therapeutic horizons
2026
Severe Central Nervous System Fungal Infection Following Tirabrutinib Administration in a Patient with Refractory Primary Central Nervous System Lymphoma: A Case Report
2026
Giant left main coronary artery aneurysm in a young adult female with suspected incomplete Kawasaki disease: a case report
2026
A sample from the 100 top papers behind Vasculitis.
Create a free account to browse them all →
Vasculitis's history
Research intensity over time
Explore Vasculitis's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Vasculitis's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link